> top > docs > PubMed:1823160 > annotations

PubMed:1823160 JSONTXT

Annnotations TAB JSON ListView MergeView

Glycan-Motif

Id Subject Object Predicate Lexical cue
T1 19-40 https://glytoucan.org/Structures/Glycans/G27025MB denotes N-acetylgalactosamine
T2 871-882 https://glytoucan.org/Structures/Glycans/G81533KY denotes sialic acid
T3 1105-1124 https://glytoucan.org/Structures/Glycans/G00055MO denotes N-acetyllactosamine

GlyCosmos6-Glycan-Motif-Image

Id Subject Object Predicate Lexical cue image
T1 19-40 Glycan_Motif denotes N-acetylgalactosamine https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G27025MB
T2 871-882 Glycan_Motif denotes sialic acid https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81533KY
T3 1105-1124 Glycan_Motif denotes N-acetyllactosamine https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00055MO

Glycosmos6-MAT

Id Subject Object Predicate Lexical cue
T1 838-846 http://purl.obolibrary.org/obo/MAT_0000086 denotes antennae
T2 976-984 http://purl.obolibrary.org/obo/MAT_0000086 denotes antennae

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-159 Sentence denotes A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator.
TextSentencer_T2 160-443 Sentence denotes We have employed fast atom bombardment mass spectrometry (FAB-MS) to screen the N-linked oligosaccharides of Bowes melanoma tissue plasminogen activator (mt-PA), and recombinant t-PAs produced by Chinese hamster ovary cells (rt-PA) and by a gene-enriched melanoma cell line (rmt-PA).
TextSentencer_T3 444-581 Sentence denotes These studies have confirmed the published structures for rt-PA, but are not in agreement with some of the structures reported for mt-PA.
TextSentencer_T4 582-707 Sentence denotes In the latter glycoprotein we have identified a novel structure as the major oligosaccharide attached to Asn-184 and Asn-448.
TextSentencer_T5 708-922 Sentence denotes This is a biantennary oligosaccharide consisting of a fucosylated trimannosyl core to which are attached two GalNAc(1----4)GlcNAc antennae, one of which carries a sialic acid linked at the 6-position of the GalNAc.
TextSentencer_T6 923-985 Sentence denotes Minor constituents are sialylated on both or neither antennae.
TextSentencer_T7 986-1051 Sentence denotes The sialylated GalNAc moiety is unique in N-linked glycoproteins.
TextSentencer_T8 1052-1254 Sentence denotes The majority of complex structures in rmt-PA contain N-acetyllactosamine moieties at both the Asn-184 and Asn-448 sites with the novel oligosaccharide occurring as a minor component at the Asn-184 site.
TextSentencer_T9 1255-1428 Sentence denotes This study demonstrates the power of mass spectrometric strategies based on high-field two-sector FAB-MS for structure elucidations of natural and recombinant glycoproteins.
T1 0-159 Sentence denotes A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator.
T2 160-443 Sentence denotes We have employed fast atom bombardment mass spectrometry (FAB-MS) to screen the N-linked oligosaccharides of Bowes melanoma tissue plasminogen activator (mt-PA), and recombinant t-PAs produced by Chinese hamster ovary cells (rt-PA) and by a gene-enriched melanoma cell line (rmt-PA).
T3 444-581 Sentence denotes These studies have confirmed the published structures for rt-PA, but are not in agreement with some of the structures reported for mt-PA.
T4 582-707 Sentence denotes In the latter glycoprotein we have identified a novel structure as the major oligosaccharide attached to Asn-184 and Asn-448.
T5 708-922 Sentence denotes This is a biantennary oligosaccharide consisting of a fucosylated trimannosyl core to which are attached two GalNAc(1----4)GlcNAc antennae, one of which carries a sialic acid linked at the 6-position of the GalNAc.
T6 923-985 Sentence denotes Minor constituents are sialylated on both or neither antennae.
T7 986-1051 Sentence denotes The sialylated GalNAc moiety is unique in N-linked glycoproteins.
T8 1052-1254 Sentence denotes The majority of complex structures in rmt-PA contain N-acetyllactosamine moieties at both the Asn-184 and Asn-448 sites with the novel oligosaccharide occurring as a minor component at the Asn-184 site.
T9 1255-1428 Sentence denotes This study demonstrates the power of mass spectrometric strategies based on high-field two-sector FAB-MS for structure elucidations of natural and recombinant glycoproteins.
T1 0-159 Sentence denotes A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator.
T2 160-443 Sentence denotes We have employed fast atom bombardment mass spectrometry (FAB-MS) to screen the N-linked oligosaccharides of Bowes melanoma tissue plasminogen activator (mt-PA), and recombinant t-PAs produced by Chinese hamster ovary cells (rt-PA) and by a gene-enriched melanoma cell line (rmt-PA).
T3 444-581 Sentence denotes These studies have confirmed the published structures for rt-PA, but are not in agreement with some of the structures reported for mt-PA.
T4 582-707 Sentence denotes In the latter glycoprotein we have identified a novel structure as the major oligosaccharide attached to Asn-184 and Asn-448.
T5 708-922 Sentence denotes This is a biantennary oligosaccharide consisting of a fucosylated trimannosyl core to which are attached two GalNAc(1----4)GlcNAc antennae, one of which carries a sialic acid linked at the 6-position of the GalNAc.
T6 923-985 Sentence denotes Minor constituents are sialylated on both or neither antennae.
T7 986-1051 Sentence denotes The sialylated GalNAc moiety is unique in N-linked glycoproteins.
T8 1052-1254 Sentence denotes The majority of complex structures in rmt-PA contain N-acetyllactosamine moieties at both the Asn-184 and Asn-448 sites with the novel oligosaccharide occurring as a minor component at the Asn-184 site.
T9 1255-1428 Sentence denotes This study demonstrates the power of mass spectrometric strategies based on high-field two-sector FAB-MS for structure elucidations of natural and recombinant glycoproteins.

GlyCosmos6-Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 19-40 https://glytoucan.org/Structures/Glycans/G27025MB denotes N-acetylgalactosamine
T2 871-882 https://glytoucan.org/Structures/Glycans/G81533KY denotes sialic acid
T3 1105-1124 https://glytoucan.org/Structures/Glycans/G00055MO denotes N-acetyllactosamine

DisGeNET

Id Subject Object Predicate Lexical cue
T0 130-158 gene:100128998 denotes tissue plasminogen activator
T1 121-129 disease:C0025202 denotes melanoma
T2 218-221 gene:2187 denotes FAB
T3 415-423 disease:C0025202 denotes melanoma
T4 218-221 gene:2187 denotes FAB
T5 275-283 disease:C0025202 denotes melanoma
R1 T0 T1 associated_with tissue plasminogen activator,melanoma
R2 T2 T3 associated_with FAB,melanoma
R3 T4 T5 associated_with FAB,melanoma

GlycoBiology-FMA

Id Subject Object Predicate Lexical cue
_T1 19-40 FMAID:196780 denotes N-acetylgalactosamine
_T2 19-40 FMAID:82786 denotes N-acetylgalactosamine
_T3 52-67 FMAID:196731 denotes oligosaccharide
_T4 52-67 FMAID:82742 denotes oligosaccharide
_T5 130-136 FMAID:256050 denotes tissue
_T6 249-265 FMAID:82742 denotes oligosaccharides
_T7 249-265 FMAID:196731 denotes oligosaccharides
_T8 284-290 FMAID:256050 denotes tissue
_T9 372-377 FMAID:7209 denotes ovary
_T10 372-377 FMAID:93687 denotes ovary
_T11 378-383 FMAID:169002 denotes cells
_T12 378-383 FMAID:68646 denotes cells
_T13 385-387 FMAID:272963 denotes rt
_T14 401-405 FMAID:198663 denotes gene
_T15 502-504 FMAID:272963 denotes rt
_T16 589-595 FMAID:171168 denotes latter
_T17 589-595 FMAID:30332 denotes latter
_T18 596-608 FMAID:167256 denotes glycoprotein
_T19 596-608 FMAID:62925 denotes glycoprotein
_T20 659-674 FMAID:196731 denotes oligosaccharide
_T21 659-674 FMAID:82742 denotes oligosaccharide
_T22 730-745 FMAID:196731 denotes oligosaccharide
_T23 730-745 FMAID:82742 denotes oligosaccharide
_T24 1037-1050 FMAID:167256 denotes glycoproteins
_T25 1037-1050 FMAID:62925 denotes glycoproteins
_T26 1105-1124 FMAID:82786 denotes N-acetyllactosamine
_T27 1105-1124 FMAID:196780 denotes N-acetyllactosamine
_T28 1187-1202 FMAID:82742 denotes oligosaccharide
_T29 1187-1202 FMAID:196731 denotes oligosaccharide
_T30 1414-1427 FMAID:167256 denotes glycoproteins
_T31 1414-1427 FMAID:62925 denotes glycoproteins

uniprot-human

Id Subject Object Predicate Lexical cue
T1 137-148 http://www.uniprot.org/uniprot/P00747 denotes plasminogen
T2 291-302 http://www.uniprot.org/uniprot/P00747 denotes plasminogen
T3 222-224 http://www.uniprot.org/uniprot/Q99707 denotes MS
T4 1357-1359 http://www.uniprot.org/uniprot/Q99707 denotes MS
T5 317-319 http://www.uniprot.org/uniprot/P04746 denotes PA
T6 388-390 http://www.uniprot.org/uniprot/P04746 denotes PA
T7 439-441 http://www.uniprot.org/uniprot/P04746 denotes PA
T8 505-507 http://www.uniprot.org/uniprot/P04746 denotes PA
T9 578-580 http://www.uniprot.org/uniprot/P04746 denotes PA
T10 1094-1096 http://www.uniprot.org/uniprot/P04746 denotes PA
T11 317-319 http://www.uniprot.org/uniprot/Q9UL45 denotes PA
T12 388-390 http://www.uniprot.org/uniprot/Q9UL45 denotes PA
T13 439-441 http://www.uniprot.org/uniprot/Q9UL45 denotes PA
T14 505-507 http://www.uniprot.org/uniprot/Q9UL45 denotes PA
T15 578-580 http://www.uniprot.org/uniprot/Q9UL45 denotes PA
T16 1094-1096 http://www.uniprot.org/uniprot/Q9UL45 denotes PA

uniprot-mouse

Id Subject Object Predicate Lexical cue
T1 137-148 http://www.uniprot.org/uniprot/P20918 denotes plasminogen
T2 291-302 http://www.uniprot.org/uniprot/P20918 denotes plasminogen
T3 222-224 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T4 1357-1359 http://www.uniprot.org/uniprot/A6H5Y3 denotes MS
T5 314-316 http://www.uniprot.org/uniprot/Q8R3F5 denotes mt
T6 575-577 http://www.uniprot.org/uniprot/Q8R3F5 denotes mt
T7 317-319 http://www.uniprot.org/uniprot/P00688 denotes PA
T8 388-390 http://www.uniprot.org/uniprot/P00688 denotes PA
T9 439-441 http://www.uniprot.org/uniprot/P00688 denotes PA
T10 505-507 http://www.uniprot.org/uniprot/P00688 denotes PA
T11 578-580 http://www.uniprot.org/uniprot/P00688 denotes PA
T12 1094-1096 http://www.uniprot.org/uniprot/P00688 denotes PA
T13 687-690 http://www.uniprot.org/uniprot/Q61024 denotes Asn
T14 699-702 http://www.uniprot.org/uniprot/Q61024 denotes Asn
T15 1146-1149 http://www.uniprot.org/uniprot/Q61024 denotes Asn
T16 1158-1161 http://www.uniprot.org/uniprot/Q61024 denotes Asn
T17 1241-1244 http://www.uniprot.org/uniprot/Q61024 denotes Asn

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T1 121-129 http://purl.bioontology.org/ontology/NCBITAXON/1369386 denotes melanoma
T2 121-129 http://purl.bioontology.org/ontology/NCBITAXON/45308 denotes melanoma
T3 130-136 http://purl.bioontology.org/ontology/STY/T024 denotes tissue
T4 275-283 http://purl.bioontology.org/ontology/NCBITAXON/45308 denotes melanoma
T5 275-283 http://purl.bioontology.org/ontology/NCBITAXON/1369386 denotes melanoma
T6 284-290 http://purl.bioontology.org/ontology/STY/T024 denotes tissue
T7 378-383 http://purl.bioontology.org/ontology/STY/T025 denotes cells
T8 415-423 http://purl.bioontology.org/ontology/NCBITAXON/45308 denotes melanoma
T9 415-423 http://purl.bioontology.org/ontology/NCBITAXON/1369386 denotes melanoma
T10 838-846 http://purl.bioontology.org/ontology/NCBITAXON/293542 denotes antennae
T11 976-984 http://purl.bioontology.org/ontology/NCBITAXON/293542 denotes antennae

GO-BP

Id Subject Object Predicate Lexical cue
T1 8-18 http://purl.obolibrary.org/obo/GO_0097503 denotes sialylated
T2 946-956 http://purl.obolibrary.org/obo/GO_0097503 denotes sialylated
T3 990-1000 http://purl.obolibrary.org/obo/GO_0097503 denotes sialylated
T4 137-158 http://purl.obolibrary.org/obo/GO_0031639 denotes plasminogen activator
T5 291-312 http://purl.obolibrary.org/obo/GO_0031639 denotes plasminogen activator
T6 177-181 http://purl.obolibrary.org/obo/GO_0033867 denotes fast
T7 385-387 http://purl.obolibrary.org/obo/GO_0003964 denotes rt
T8 502-504 http://purl.obolibrary.org/obo/GO_0003964 denotes rt
T9 762-773 http://purl.obolibrary.org/obo/GO_0036065 denotes fucosylated
T10 1028-1050 http://purl.obolibrary.org/obo/GO_0006491 denotes N-linked glycoproteins

GO-CC

Id Subject Object Predicate Lexical cue
T1 340-343 http://purl.obolibrary.org/obo/GO_0000407 denotes PAs
T2 378-383 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T3 424-428 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T4 786-790 http://purl.obolibrary.org/obo/GO_0019013 denotes core

UBERON-AE

Id Subject Object Predicate Lexical cue
T1 130-136 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
T2 284-290 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
T3 838-846 http://purl.obolibrary.org/obo/UBERON_0000972 denotes antennae
T4 976-984 http://purl.obolibrary.org/obo/UBERON_0000972 denotes antennae

EDAM-topics

Id Subject Object Predicate Lexical cue
T1 199-216 http://edamontology.org/topic_0134 denotes mass spectrometry
T2 199-216 http://edamontology.org/topic_3520 denotes mass spectrometry
T3 450-457 http://edamontology.org/topic_3678 denotes studies
T4 1260-1265 http://edamontology.org/topic_3678 denotes study
T5 1292-1310 http://edamontology.org/topic_3520 denotes mass spectrometric
T6 1292-1310 http://edamontology.org/topic_0134 denotes mass spectrometric

EDAM-DFO

Id Subject Object Predicate Lexical cue
T1 94-103 http://edamontology.org/data_0883 denotes structure
T2 199-216 http://edamontology.org/data_2536 denotes mass spectrometry
T3 199-216 http://edamontology.org/data_3147 denotes mass spectrometry
T4 487-497 http://edamontology.org/data_0883 denotes structures
T5 487-501 http://edamontology.org/operation_1848 denotes structures for
T6 551-561 http://edamontology.org/data_0883 denotes structures
T7 551-570 http://edamontology.org/data_2085 denotes structures reported
T8 551-570 http://edamontology.org/data_0887 denotes structures reported
T9 562-570 http://edamontology.org/data_2048 denotes reported
T10 617-627 http://edamontology.org/data_2611 denotes identified
T11 617-627 http://edamontology.org/data_0842 denotes identified
T12 636-645 http://edamontology.org/data_0883 denotes structure
T13 1076-1086 http://edamontology.org/data_0883 denotes structures
T14 1076-1089 http://edamontology.org/data_1070 denotes structures in
T15 1266-1278 http://edamontology.org/operation_2246 denotes demonstrates
T16 1292-1310 http://edamontology.org/data_2536 denotes mass spectrometric
T17 1364-1373 http://edamontology.org/data_0883 denotes structure

NGLY1-deficiency

Id Subject Object Predicate Lexical cue
PD-NGLY1-deficiency-B_T1 831-837 chem:24139 denotes GlcNAc

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
1823160-0#130#158#gene100128998 130-158 gene100128998 denotes tissue plasminogen activator
1823160-0#121#129#diseaseC0025202 121-129 diseaseC0025202 denotes melanoma
1823160-1#58#61#gene2187 218-221 gene2187 denotes FAB
1823160-1#115#123#diseaseC0025202 275-283 diseaseC0025202 denotes melanoma
1823160-1#255#263#diseaseC0025202 415-423 diseaseC0025202 denotes melanoma
130#158#gene100128998121#129#diseaseC0025202 1823160-0#130#158#gene100128998 1823160-0#121#129#diseaseC0025202 associated_with tissue plasminogen activator,melanoma
58#61#gene2187115#123#diseaseC0025202 1823160-1#58#61#gene2187 1823160-1#115#123#diseaseC0025202 associated_with FAB,melanoma
58#61#gene2187255#263#diseaseC0025202 1823160-1#58#61#gene2187 1823160-1#255#263#diseaseC0025202 associated_with FAB,melanoma

GlycoBiology-MAT

Id Subject Object Predicate Lexical cue
T1 589-595 http://purl.obolibrary.org/obo/MAT_0000488 denotes latter
T2 838-846 http://purl.obolibrary.org/obo/MAT_0000086 denotes antennae
T3 976-984 http://purl.obolibrary.org/obo/MAT_0000086 denotes antennae

GlyTouCan-IUPAC

Id Subject Object Predicate Lexical cue
GlycanIUPAC_T1 817-823 "http://rdf.glycoinfo.org/glycan/G23425WZ" denotes GalNAc
GlycanIUPAC_T2 915-921 "http://rdf.glycoinfo.org/glycan/G23425WZ" denotes GalNAc
GlycanIUPAC_T3 1001-1007 "http://rdf.glycoinfo.org/glycan/G23425WZ" denotes GalNAc
GlycanIUPAC_T4 817-823 "http://rdf.glycoinfo.org/glycan/G02874VH" denotes GalNAc
GlycanIUPAC_T5 915-921 "http://rdf.glycoinfo.org/glycan/G02874VH" denotes GalNAc
GlycanIUPAC_T6 1001-1007 "http://rdf.glycoinfo.org/glycan/G02874VH" denotes GalNAc
GlycanIUPAC_T7 817-823 "http://rdf.glycoinfo.org/glycan/G99699DW" denotes GalNAc
GlycanIUPAC_T8 915-921 "http://rdf.glycoinfo.org/glycan/G99699DW" denotes GalNAc
GlycanIUPAC_T9 1001-1007 "http://rdf.glycoinfo.org/glycan/G99699DW" denotes GalNAc
GlycanIUPAC_T10 817-823 "http://rdf.glycoinfo.org/glycan/G22074RM" denotes GalNAc
GlycanIUPAC_T11 915-921 "http://rdf.glycoinfo.org/glycan/G22074RM" denotes GalNAc
GlycanIUPAC_T12 1001-1007 "http://rdf.glycoinfo.org/glycan/G22074RM" denotes GalNAc
GlycanIUPAC_T13 817-823 "http://rdf.glycoinfo.org/glycan/G48535VZ" denotes GalNAc
GlycanIUPAC_T14 915-921 "http://rdf.glycoinfo.org/glycan/G48535VZ" denotes GalNAc
GlycanIUPAC_T15 1001-1007 "http://rdf.glycoinfo.org/glycan/G48535VZ" denotes GalNAc
GlycanIUPAC_T16 817-823 "http://rdf.glycoinfo.org/glycan/G39738WL" denotes GalNAc
GlycanIUPAC_T17 915-921 "http://rdf.glycoinfo.org/glycan/G39738WL" denotes GalNAc
GlycanIUPAC_T18 1001-1007 "http://rdf.glycoinfo.org/glycan/G39738WL" denotes GalNAc
GlycanIUPAC_T19 817-823 "http://rdf.glycoinfo.org/glycan/G42313WU" denotes GalNAc
GlycanIUPAC_T20 915-921 "http://rdf.glycoinfo.org/glycan/G42313WU" denotes GalNAc
GlycanIUPAC_T21 1001-1007 "http://rdf.glycoinfo.org/glycan/G42313WU" denotes GalNAc
GlycanIUPAC_T22 817-823 "http://rdf.glycoinfo.org/glycan/G00393CK" denotes GalNAc
GlycanIUPAC_T23 915-921 "http://rdf.glycoinfo.org/glycan/G00393CK" denotes GalNAc
GlycanIUPAC_T24 1001-1007 "http://rdf.glycoinfo.org/glycan/G00393CK" denotes GalNAc
GlycanIUPAC_T25 817-823 "http://rdf.glycoinfo.org/glycan/G42649EX" denotes GalNAc
GlycanIUPAC_T26 915-921 "http://rdf.glycoinfo.org/glycan/G42649EX" denotes GalNAc
GlycanIUPAC_T27 1001-1007 "http://rdf.glycoinfo.org/glycan/G42649EX" denotes GalNAc
GlycanIUPAC_T28 817-823 "http://rdf.glycoinfo.org/glycan/G46880SB" denotes GalNAc
GlycanIUPAC_T29 915-921 "http://rdf.glycoinfo.org/glycan/G46880SB" denotes GalNAc
GlycanIUPAC_T30 1001-1007 "http://rdf.glycoinfo.org/glycan/G46880SB" denotes GalNAc
GlycanIUPAC_T31 817-823 "http://rdf.glycoinfo.org/glycan/G75599IR" denotes GalNAc
GlycanIUPAC_T32 915-921 "http://rdf.glycoinfo.org/glycan/G75599IR" denotes GalNAc
GlycanIUPAC_T33 1001-1007 "http://rdf.glycoinfo.org/glycan/G75599IR" denotes GalNAc
GlycanIUPAC_T34 817-823 "http://rdf.glycoinfo.org/glycan/G58985MU" denotes GalNAc
GlycanIUPAC_T35 915-921 "http://rdf.glycoinfo.org/glycan/G58985MU" denotes GalNAc
GlycanIUPAC_T36 1001-1007 "http://rdf.glycoinfo.org/glycan/G58985MU" denotes GalNAc
GlycanIUPAC_T37 817-823 "http://rdf.glycoinfo.org/glycan/G92517PO" denotes GalNAc
GlycanIUPAC_T38 915-921 "http://rdf.glycoinfo.org/glycan/G92517PO" denotes GalNAc
GlycanIUPAC_T39 1001-1007 "http://rdf.glycoinfo.org/glycan/G92517PO" denotes GalNAc
GlycanIUPAC_T40 817-823 "http://rdf.glycoinfo.org/glycan/G88512YL" denotes GalNAc
GlycanIUPAC_T41 915-921 "http://rdf.glycoinfo.org/glycan/G88512YL" denotes GalNAc
GlycanIUPAC_T42 1001-1007 "http://rdf.glycoinfo.org/glycan/G88512YL" denotes GalNAc
GlycanIUPAC_T43 817-823 "http://rdf.glycoinfo.org/glycan/G41473NX" denotes GalNAc
GlycanIUPAC_T44 915-921 "http://rdf.glycoinfo.org/glycan/G41473NX" denotes GalNAc
GlycanIUPAC_T45 1001-1007 "http://rdf.glycoinfo.org/glycan/G41473NX" denotes GalNAc
GlycanIUPAC_T46 817-823 "http://rdf.glycoinfo.org/glycan/G71089RB" denotes GalNAc
GlycanIUPAC_T47 915-921 "http://rdf.glycoinfo.org/glycan/G71089RB" denotes GalNAc
GlycanIUPAC_T48 1001-1007 "http://rdf.glycoinfo.org/glycan/G71089RB" denotes GalNAc
GlycanIUPAC_T49 817-823 "http://rdf.glycoinfo.org/glycan/G73485GZ" denotes GalNAc
GlycanIUPAC_T50 915-921 "http://rdf.glycoinfo.org/glycan/G73485GZ" denotes GalNAc
GlycanIUPAC_T51 1001-1007 "http://rdf.glycoinfo.org/glycan/G73485GZ" denotes GalNAc
GlycanIUPAC_T52 817-823 "http://rdf.glycoinfo.org/glycan/G61406KC" denotes GalNAc
GlycanIUPAC_T53 915-921 "http://rdf.glycoinfo.org/glycan/G61406KC" denotes GalNAc
GlycanIUPAC_T54 1001-1007 "http://rdf.glycoinfo.org/glycan/G61406KC" denotes GalNAc
GlycanIUPAC_T55 817-823 "http://rdf.glycoinfo.org/glycan/G34412GZ" denotes GalNAc
GlycanIUPAC_T56 915-921 "http://rdf.glycoinfo.org/glycan/G34412GZ" denotes GalNAc
GlycanIUPAC_T57 1001-1007 "http://rdf.glycoinfo.org/glycan/G34412GZ" denotes GalNAc
GlycanIUPAC_T58 817-823 "http://rdf.glycoinfo.org/glycan/G67209FP" denotes GalNAc
GlycanIUPAC_T59 915-921 "http://rdf.glycoinfo.org/glycan/G67209FP" denotes GalNAc
GlycanIUPAC_T60 1001-1007 "http://rdf.glycoinfo.org/glycan/G67209FP" denotes GalNAc
GlycanIUPAC_T61 817-823 "http://rdf.glycoinfo.org/glycan/G61442IL" denotes GalNAc
GlycanIUPAC_T62 915-921 "http://rdf.glycoinfo.org/glycan/G61442IL" denotes GalNAc
GlycanIUPAC_T63 1001-1007 "http://rdf.glycoinfo.org/glycan/G61442IL" denotes GalNAc
GlycanIUPAC_T64 817-823 "http://rdf.glycoinfo.org/glycan/G93729MV" denotes GalNAc
GlycanIUPAC_T65 915-921 "http://rdf.glycoinfo.org/glycan/G93729MV" denotes GalNAc
GlycanIUPAC_T66 1001-1007 "http://rdf.glycoinfo.org/glycan/G93729MV" denotes GalNAc
GlycanIUPAC_T67 817-823 "http://rdf.glycoinfo.org/glycan/G92144AE" denotes GalNAc
GlycanIUPAC_T68 915-921 "http://rdf.glycoinfo.org/glycan/G92144AE" denotes GalNAc
GlycanIUPAC_T69 1001-1007 "http://rdf.glycoinfo.org/glycan/G92144AE" denotes GalNAc
GlycanIUPAC_T70 817-825 "http://rdf.glycoinfo.org/glycan/G56558YT" denotes GalNAc(1
GlycanIUPAC_T71 817-825 "http://rdf.glycoinfo.org/glycan/G83430HE" denotes GalNAc(1
GlycanIUPAC_T72 817-825 "http://rdf.glycoinfo.org/glycan/G27025MB" denotes GalNAc(1
GlycanIUPAC_T73 817-825 "http://rdf.glycoinfo.org/glycan/G48828SZ" denotes GalNAc(1
GlycanIUPAC_T74 817-825 "http://rdf.glycoinfo.org/glycan/G70697FM" denotes GalNAc(1
GlycanIUPAC_T75 817-825 "http://rdf.glycoinfo.org/glycan/G42945ZI" denotes GalNAc(1
GlycanIUPAC_T76 831-837 "http://rdf.glycoinfo.org/glycan/G26693XF" denotes GlcNAc
GlycanIUPAC_T77 831-837 "http://rdf.glycoinfo.org/glycan/G01864SU" denotes GlcNAc
GlycanIUPAC_T78 831-837 "http://rdf.glycoinfo.org/glycan/G17605FD" denotes GlcNAc
GlycanIUPAC_T79 831-837 "http://rdf.glycoinfo.org/glycan/G41950LU" denotes GlcNAc
GlycanIUPAC_T80 831-837 "http://rdf.glycoinfo.org/glycan/G57195RJ" denotes GlcNAc
GlycanIUPAC_T81 831-837 "http://rdf.glycoinfo.org/glycan/G85391SA" denotes GlcNAc
GlycanIUPAC_T82 831-837 "http://rdf.glycoinfo.org/glycan/G89565QL" denotes GlcNAc
GlycanIUPAC_T83 831-837 "http://rdf.glycoinfo.org/glycan/G80869MR" denotes GlcNAc
GlycanIUPAC_T84 831-837 "http://rdf.glycoinfo.org/glycan/G55978NL" denotes GlcNAc
GlycanIUPAC_T85 831-837 "http://rdf.glycoinfo.org/glycan/G54644LT" denotes GlcNAc
GlycanIUPAC_T86 831-837 "http://rdf.glycoinfo.org/glycan/G25694UG" denotes GlcNAc
GlycanIUPAC_T87 831-837 "http://rdf.glycoinfo.org/glycan/G25126RB" denotes GlcNAc
GlycanIUPAC_T88 831-837 "http://rdf.glycoinfo.org/glycan/G51848AD" denotes GlcNAc
GlycanIUPAC_T89 831-837 "http://rdf.glycoinfo.org/glycan/G94667GM" denotes GlcNAc
GlycanIUPAC_T90 831-837 "http://rdf.glycoinfo.org/glycan/G30124BO" denotes GlcNAc
GlycanIUPAC_T91 831-837 "http://rdf.glycoinfo.org/glycan/G82777EZ" denotes GlcNAc
GlycanIUPAC_T92 831-837 "http://rdf.glycoinfo.org/glycan/G10151YZ" denotes GlcNAc
GlycanIUPAC_T93 831-837 "http://rdf.glycoinfo.org/glycan/G17585ZM" denotes GlcNAc
GlycanIUPAC_T94 831-837 "http://rdf.glycoinfo.org/glycan/G04411CJ" denotes GlcNAc
GlycanIUPAC_T95 831-837 "http://rdf.glycoinfo.org/glycan/G38254HJ" denotes GlcNAc
GlycanIUPAC_T96 831-837 "http://rdf.glycoinfo.org/glycan/G75188FS" denotes GlcNAc
GlycanIUPAC_T97 831-837 "http://rdf.glycoinfo.org/glycan/G70374VG" denotes GlcNAc
GlycanIUPAC_T98 831-837 "http://rdf.glycoinfo.org/glycan/G45176LJ" denotes GlcNAc
GlycanIUPAC_T99 831-837 "http://rdf.glycoinfo.org/glycan/G30874VW" denotes GlcNAc
GlycanIUPAC_T100 831-837 "http://rdf.glycoinfo.org/glycan/G69333MI" denotes GlcNAc
GlycanIUPAC_T101 831-837 "http://rdf.glycoinfo.org/glycan/G10676XO" denotes GlcNAc
GlycanIUPAC_T102 831-837 "http://rdf.glycoinfo.org/glycan/G14843DJ" denotes GlcNAc
GlycanIUPAC_T103 831-837 "http://rdf.glycoinfo.org/glycan/G47546FR" denotes GlcNAc
GlycanIUPAC_T104 831-837 "http://rdf.glycoinfo.org/glycan/G73695ZM" denotes GlcNAc
GlycanIUPAC_T105 831-837 "http://rdf.glycoinfo.org/glycan/G31923TJ" denotes GlcNAc
GlycanIUPAC_T106 831-837 "http://rdf.glycoinfo.org/glycan/G60519EP" denotes GlcNAc
GlycanIUPAC_T107 831-837 "http://rdf.glycoinfo.org/glycan/G07933IA" denotes GlcNAc
GlycanIUPAC_T108 831-837 "http://rdf.glycoinfo.org/glycan/G40745NH" denotes GlcNAc
GlycanIUPAC_T109 831-837 "http://rdf.glycoinfo.org/glycan/G54496YV" denotes GlcNAc
GlycanIUPAC_T110 831-837 "http://rdf.glycoinfo.org/glycan/G62953SQ" denotes GlcNAc
GlycanIUPAC_T111 831-837 "http://rdf.glycoinfo.org/glycan/G70070AY" denotes GlcNAc
GlycanIUPAC_T112 831-837 "http://rdf.glycoinfo.org/glycan/G78792WC" denotes GlcNAc
GlycanIUPAC_T113 831-837 "http://rdf.glycoinfo.org/glycan/G25238AV" denotes GlcNAc
GlycanIUPAC_T114 831-837 "http://rdf.glycoinfo.org/glycan/G40510DP" denotes GlcNAc
GlycanIUPAC_T115 831-837 "http://rdf.glycoinfo.org/glycan/G61120TK" denotes GlcNAc
GlycanIUPAC_T116 831-837 "http://rdf.glycoinfo.org/glycan/G41342KV" denotes GlcNAc
GlycanIUPAC_T117 831-837 "http://rdf.glycoinfo.org/glycan/G90703NA" denotes GlcNAc
GlycanIUPAC_T118 831-837 "http://rdf.glycoinfo.org/glycan/G01591HR" denotes GlcNAc
GlycanIUPAC_T119 831-837 "http://rdf.glycoinfo.org/glycan/G56520XN" denotes GlcNAc
GlycanIUPAC_T120 831-837 "http://rdf.glycoinfo.org/glycan/G81830JX" denotes GlcNAc

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 130-136 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
PD-UBERON-AE-B_T2 284-290 http://purl.obolibrary.org/obo/UBERON_0000479 denotes tissue
PD-UBERON-AE-B_T3 838-846 http://purl.obolibrary.org/obo/UBERON_0000972 denotes antennae
PD-UBERON-AE-B_T4 976-984 http://purl.obolibrary.org/obo/UBERON_0000972 denotes antennae

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T1 121-129 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T2 275-283 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T3 415-423 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105

HP-phenotype

Id Subject Object Predicate Lexical cue hp_id
T1 121-129 Phenotype denotes melanoma HP:0002861
T2 275-283 Phenotype denotes melanoma HP:0002861
T3 415-423 Phenotype denotes melanoma HP:0002861

Glycan-GlyCosmos

Id Subject Object Predicate Lexical cue image
T1 817-823 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T2 915-921 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T3 1001-1007 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL

GlyCosmos15-HP

Id Subject Object Predicate Lexical cue hp_id
T1 121-129 Phenotype denotes melanoma HP:0002861
T2 275-283 Phenotype denotes melanoma HP:0002861
T3 415-423 Phenotype denotes melanoma HP:0002861

GlyCosmos15-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 121-129 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T2 275-283 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105
T3 415-423 Disease denotes melanoma http://purl.obolibrary.org/obo/MONDO_0005105

GlyCosmos15-NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 356-371 OrganismTaxon denotes Chinese hamster 10029

GlyCosmos15-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 130-136 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T2 284-290 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T3 372-377 Body_part denotes ovary http://purl.obolibrary.org/obo/UBERON_0000992

GlyCosmos15-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 838-846 Body_part denotes antennae http://purl.obolibrary.org/obo/MAT_0000086
T2 976-984 Body_part denotes antennae http://purl.obolibrary.org/obo/MAT_0000086

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-159 Sentence denotes A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator.
TextSentencer_T2 160-443 Sentence denotes We have employed fast atom bombardment mass spectrometry (FAB-MS) to screen the N-linked oligosaccharides of Bowes melanoma tissue plasminogen activator (mt-PA), and recombinant t-PAs produced by Chinese hamster ovary cells (rt-PA) and by a gene-enriched melanoma cell line (rmt-PA).
TextSentencer_T3 444-581 Sentence denotes These studies have confirmed the published structures for rt-PA, but are not in agreement with some of the structures reported for mt-PA.
TextSentencer_T4 582-707 Sentence denotes In the latter glycoprotein we have identified a novel structure as the major oligosaccharide attached to Asn-184 and Asn-448.
TextSentencer_T5 708-922 Sentence denotes This is a biantennary oligosaccharide consisting of a fucosylated trimannosyl core to which are attached two GalNAc(1----4)GlcNAc antennae, one of which carries a sialic acid linked at the 6-position of the GalNAc.
TextSentencer_T6 923-985 Sentence denotes Minor constituents are sialylated on both or neither antennae.
TextSentencer_T7 986-1051 Sentence denotes The sialylated GalNAc moiety is unique in N-linked glycoproteins.
TextSentencer_T8 1052-1254 Sentence denotes The majority of complex structures in rmt-PA contain N-acetyllactosamine moieties at both the Asn-184 and Asn-448 sites with the novel oligosaccharide occurring as a minor component at the Asn-184 site.
TextSentencer_T9 1255-1428 Sentence denotes This study demonstrates the power of mass spectrometric strategies based on high-field two-sector FAB-MS for structure elucidations of natural and recombinant glycoproteins.
T1 0-159 Sentence denotes A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator.
T2 160-443 Sentence denotes We have employed fast atom bombardment mass spectrometry (FAB-MS) to screen the N-linked oligosaccharides of Bowes melanoma tissue plasminogen activator (mt-PA), and recombinant t-PAs produced by Chinese hamster ovary cells (rt-PA) and by a gene-enriched melanoma cell line (rmt-PA).
T3 444-581 Sentence denotes These studies have confirmed the published structures for rt-PA, but are not in agreement with some of the structures reported for mt-PA.
T4 582-707 Sentence denotes In the latter glycoprotein we have identified a novel structure as the major oligosaccharide attached to Asn-184 and Asn-448.
T5 708-922 Sentence denotes This is a biantennary oligosaccharide consisting of a fucosylated trimannosyl core to which are attached two GalNAc(1----4)GlcNAc antennae, one of which carries a sialic acid linked at the 6-position of the GalNAc.
T6 923-985 Sentence denotes Minor constituents are sialylated on both or neither antennae.
T7 986-1051 Sentence denotes The sialylated GalNAc moiety is unique in N-linked glycoproteins.
T8 1052-1254 Sentence denotes The majority of complex structures in rmt-PA contain N-acetyllactosamine moieties at both the Asn-184 and Asn-448 sites with the novel oligosaccharide occurring as a minor component at the Asn-184 site.
T9 1255-1428 Sentence denotes This study demonstrates the power of mass spectrometric strategies based on high-field two-sector FAB-MS for structure elucidations of natural and recombinant glycoproteins.
T1 0-159 Sentence denotes A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator.
T2 160-443 Sentence denotes We have employed fast atom bombardment mass spectrometry (FAB-MS) to screen the N-linked oligosaccharides of Bowes melanoma tissue plasminogen activator (mt-PA), and recombinant t-PAs produced by Chinese hamster ovary cells (rt-PA) and by a gene-enriched melanoma cell line (rmt-PA).
T3 444-581 Sentence denotes These studies have confirmed the published structures for rt-PA, but are not in agreement with some of the structures reported for mt-PA.
T4 582-707 Sentence denotes In the latter glycoprotein we have identified a novel structure as the major oligosaccharide attached to Asn-184 and Asn-448.
T5 708-922 Sentence denotes This is a biantennary oligosaccharide consisting of a fucosylated trimannosyl core to which are attached two GalNAc(1----4)GlcNAc antennae, one of which carries a sialic acid linked at the 6-position of the GalNAc.
T6 923-985 Sentence denotes Minor constituents are sialylated on both or neither antennae.
T7 986-1051 Sentence denotes The sialylated GalNAc moiety is unique in N-linked glycoproteins.
T8 1052-1254 Sentence denotes The majority of complex structures in rmt-PA contain N-acetyllactosamine moieties at both the Asn-184 and Asn-448 sites with the novel oligosaccharide occurring as a minor component at the Asn-184 site.
T9 1255-1428 Sentence denotes This study demonstrates the power of mass spectrometric strategies based on high-field two-sector FAB-MS for structure elucidations of natural and recombinant glycoproteins.

GlyCosmos15-Sentences

Id Subject Object Predicate Lexical cue
T1 0-159 Sentence denotes A novel sialylated N-acetylgalactosamine-containing oligosaccharide is the major complex-type structure present in Bowes melanoma tissue plasminogen activator.
T2 160-443 Sentence denotes We have employed fast atom bombardment mass spectrometry (FAB-MS) to screen the N-linked oligosaccharides of Bowes melanoma tissue plasminogen activator (mt-PA), and recombinant t-PAs produced by Chinese hamster ovary cells (rt-PA) and by a gene-enriched melanoma cell line (rmt-PA).
T3 444-581 Sentence denotes These studies have confirmed the published structures for rt-PA, but are not in agreement with some of the structures reported for mt-PA.
T4 582-707 Sentence denotes In the latter glycoprotein we have identified a novel structure as the major oligosaccharide attached to Asn-184 and Asn-448.
T5 708-922 Sentence denotes This is a biantennary oligosaccharide consisting of a fucosylated trimannosyl core to which are attached two GalNAc(1----4)GlcNAc antennae, one of which carries a sialic acid linked at the 6-position of the GalNAc.
T6 923-985 Sentence denotes Minor constituents are sialylated on both or neither antennae.
T7 986-1051 Sentence denotes The sialylated GalNAc moiety is unique in N-linked glycoproteins.
T8 1052-1254 Sentence denotes The majority of complex structures in rmt-PA contain N-acetyllactosamine moieties at both the Asn-184 and Asn-448 sites with the novel oligosaccharide occurring as a minor component at the Asn-184 site.
T9 1255-1428 Sentence denotes This study demonstrates the power of mass spectrometric strategies based on high-field two-sector FAB-MS for structure elucidations of natural and recombinant glycoproteins.

GlyCosmos15-Glycan

Id Subject Object Predicate Lexical cue image
T1 817-823 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T2 915-921 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL
T3 1001-1007 Glycan denotes GalNAc https://api.glycosmos.org/wurcs2image/latest/png/binary/G39738WL

NCBITAXON

Id Subject Object Predicate Lexical cue db_id
T1 356-371 OrganismTaxon denotes Chinese hamster 10029

Anatomy-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 130-136 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T2 284-290 Body_part denotes tissue http://purl.obolibrary.org/obo/UBERON_0000479
T3 372-377 Body_part denotes ovary http://purl.obolibrary.org/obo/UBERON_0000992

Anatomy-MAT

Id Subject Object Predicate Lexical cue mat_id
T1 838-846 Body_part denotes antennae http://purl.obolibrary.org/obo/MAT_0000086
T2 976-984 Body_part denotes antennae http://purl.obolibrary.org/obo/MAT_0000086